Report: Biotech firms secured $852M in Q3 venture investments

10/21/2013 | MedCityNews.com

The biotechnology industry secured $852 million in venture capital investments during the third quarter of 2013, 39% less than in the previous quarter, according to a new MoneyTree Report. The number of biotech-related deals increased 10%, to 123. Discerna Pharmaceuticals raised the most venture capital with $60 million, followed by Otonomy with $45.9 million and Intra-Cellular Therapies with $43 million.

View Full Article in:

MedCityNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ